It is an NMC requirement that all students have an enhanced Disclosure and Barring Service (DBS) check prior to starting the programme Self- declaration of continued health and character is completed at the start of every academic year.
Develop a critical understanding of altered health occurring in common conditions and symptoms across the adult lifespan;
Develop knowledge of pharmacology, pharmacokinetics and therapeutics of common medicines and the ability to identify differences in pharmacology raised by factors such as age, weight, route and concordance;
Undertake shared assessments and shared decision-making and facilitate transition from service to service or between care settings;
Develop further in-depth knowledge of field specific strengths-based, therapeutic adult nursing related to commonly occurring conditions;
Evaluate the effectiveness of person centred evidence-based care prioritisation and planning.
Content:
Commonly encountered physical conditions including cardiovascular, endocrine, genetic, immune, infection, gastrointestinal, haematological, hepatic, musculoskeletal, neurological, oncological, renal, respiratory systems. Visual and auditory conditions. Commonly encountered mental health conditions – mental distress and anxiety, depression, self-harm and suicidal ideation, bipolar disorder, schizophrenia, personality disorders, addiction and substance misuse. Nursing children, young people and adults with learning disabilities – including approaches to reasonable adjustments, medication management, empowerment, independence and inclusion in therapeutic management.This module aims to enable students to systematically apply knowledge of therapeutic nursing practice to the care of individuals with altered health and commonly occurring conditions within a field of practice. As part of this students will consider the impact of pharmacokinetics and pharmacotherapeutics within their field of practice. Students will critically evaluate the effectiveness of person centred evidence-based therapeutic nursing care including the safe person centred transition of care for people across a care pathway and/or integrated health and social care service.
The module will include scenarios to develop learning of assessment and observation for those at risk of deterioration in adults within the context of community, medical and surgical care settings, including the need to base therapeutic interventions on individual needs and preferences and the application of evidence.
Pharmacology and medicine optimisation will be discussed in relation to common conditions. Use of British National Formulary.
Learning and Teaching
A range of learning and teaching activities will be used, including lead lectures, digital learning packages, tutorials, case studies, involvement of service users, other agencies and professionals, as appropriate.
Learning Outcomes
By the end of the module students should be able to:
Demonstrate a critical understanding of altered physiology and mental health within commonly occurring conditions in adults;
Demonstrate critical understanding of pharmacology, pharmacokinetics and pharmacodynamics as applied to a range of adults and common medication groups and calculate drug dosages accurately;
Evaluate the effectiveness of evidence-based, holistic person centred care for an adult with a commonly occurring condition;
Discuss the principles of shared assessment and shared decision-making in supporting holistic person-centred care;
Using an evidence-based approach, defend the prioritisation of decisions made in the delivery of holistic person centred care for adults;
Analyse the role of the family and/or carers in the decision-making process and delivery of holistic care.
0% drug calculation exam (1 hour, Pass/Fail, pass mark 100%). Internal hurdle.
100% 3000-word essay (example below)
Example brief: an extended plan and evaluation of care using a provided template to include: a) A brief case study introducing the patient (and relevant family members or carers), and the reason for their admission or referral to services. b) An explanation of the patient’s medical condition including relevant pathophysiology and medications. c) A discussion of the non-pharmacological therapy, treatment, or intervention that the patient needs with evidence-based justification. d) A discussion of the way(s) that the patient’s response to treatment or ongoing assessment of their condition can be monitored.
Reassessment:
Students will resubmit or re-sit the failed component only.
Failure in SafeMedicate will require the student to engage with the online programme and sit formative assessments. Tutorial support should improvement not be achieved prior to the summative examination.
Failure is essay component will require resubmission of entire essay.